The data suggest that the increased disease severity observed in diabetes is likely due to a dysregulated immune response because of increased expression of ACE-2 (SARS-CoV-2 receptor) in diabetics; this may promote increased cellular binding to SARS-CoV-2. Here, ACE2 is linked to diabetes mellitus.